Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases

Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., Youdim, M. B. H.·1990·Journal of Neural Transmission - Parkinson's Disease and Dementia Section
DOI 10.1007/bf02252926

Cited by (445)

Items 401–445 of 445

  1. Particle Induced X-Ray Emission Examination in Post-Mortem Brains
    Jacques De Reuck · 2020 · International Journal of Research Studies in Medical and Health Sciences
  2. Iron
    Tanja Grubić Kezele · 2018 · Healthy ageing and longevity
  3. Glial heme oxygenase-1 in CNSinjury and disease
    Hyman M. Schipper · 2003 · Advances in molecular and cell biology
  4. Gene and Protein Expression Profiling in Parkinson's Disease: Quest for Neuroprotective Drugs
    Orly Weinreb, Tamar Amit, Edna Grünblatt, Peter Franz Riederer, Moussa B. H. Youdim, Silvia A. Mandel · 2007 · Springer eBooks
  5. Oxidative stress
    Mario E. Götz, Gabriella Künig, Peter Franz Riederer, Moussa B. H. Youdim · 1996 · Elsevier eBooks
  6. Systematrophien
    Werner Paulus · 1995 · Springer eBooks
  7. Iron Homeostasis and Neurodegeneration
    Robert R. Crichton · 2016
  8. Neuroprotective Strategies in Parkinson’s Disease and Huntington’s Chorea
    Moussa B. H. Youdim, Gopal A. Krishna, Chuang C. Chiueh · 2000 · Humana Press eBooks
  9. Pathogenesis of Parkinson’s disease: iron and mitochondrial DNA deletion
    Yoshikuni Mizuno, Hideki Mochizuki, Katsunori Nishi, S Ikebe, Nobutaka Hattori, Y. Hattori-Nakagawa · 1993 · Key topics in brain research
  10. Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for Neuroprotection
    Edna Grünblatt, Silvia A. Mandel, Yona Royak, Moussa B. H. Youdim · 2000 · Springer eBooks
  11. A new rodent model of Parkinson s Disease based on neuron specific downregulation of glutathione production.
    M. Garrido · 2009
  12. Novel Synchrotron-Based Analyses of Metal Pathology in Friedreich’s Ataxia
    Bogdan Florin Gh. Popescu · 2009 · University Library - University of Saskatchewan (University of Saskatchewan)
  13. Mechanisms of dopaminergic neurotoxin-induced blood-brain barrier disruption
    Niccole J. Larsen · 2007 · D-Scholarship@Pitt (University of Pittsburgh)
  14. Genetic Determinants of Cognitive Function and Age-Related Brain Changes
    Maaike Schuur · 2010 · RePub (Erasmus University Rotterdam)
  15. Progress Towards Understanding Of Mechanisms Of Action Of Potent Multifunctional Disease Modifying Therapeutics For Parkinson's Disease & Investigating The Methamphetamine-Induced Striatal Microglia Activation.
    Mrudang M. Shah · 2013 · Human Biology
  16. Brain Lipids in Ageing and in Alzheimer's Disease: A Review
    F.M. Corrigan, Steven W. Welsh, E. ROY SKINNER, David F. Horrobin · 1994 · Journal of Nutritional Medicine
  17. Recessive Parkinsonism, Mitochondria and Translational Regulation
    Jeff G. Blackinton · 2008 · Figshare
  18. Expression and function of DMT1 without IRE in C6 cells mediated by recombinant adenovirus
    Xixun Du, Huamin Xu, Hong Fu Jiang, Jun Wang, Lei Wang, Junxia Xie · 2009 · Frontiers of Medicine
  19. Parkinson's Disease as Multifactorial Oxidative Neurodegeneration: Implications
    Parris M. Kidd · 2000
  20. MRI assessment of brain iron content in methamphetamine users
    Yosef A. Berlow · 2014
  21. 14 Alzheimer's Dementia
    Seema Gulyani, Mark P. Mattson · 2010
  22. Pathological Changes in the Elderly Human Brain
    David M. A. Mann · 1997 · Springer eBooks
  23. Short original communications Increased iron content in the putamen of patients with striatonigral degeneration
    Satsuki Kato, Shunsuke Meshitsuka, Eisaku Ohama, Junichi Tanaka, J. E Llena, Atsushi Hirano · 1992
  24. The In Vitro and In Vivo Molecular Mechanisms of Neuroprotection by the Major Green Tea Polyphenol, (–)-Epigallocatechin-3-gallate, with Special Reference to Parkinson’s Disease
    Silvia A. Mandel, Tamar Amit, Moussa B. H. Youdim, Orly Weinreb · 2005 · Oxidative stress and disease
  25. Iron and Monoamine Oxidase in Brain Function and Dysfunction
    Moussa B. H. Youdim, Orly Weinreb, Silvia A. Mandel, Tamar Amit · 2009 · Oxidative stress and disease
  26. Alzheimer’s Dementia
    Seema Gulyani, Mark P. Mattson · 2009 · Humana Press eBooks
  27. BRAIN IRON DEFICIENCY IN HUMANS AND ANIMAL MODELS
    Stacey Lynn Clardy · 2005
  28. Research Priorities for Complementary Medicine in Australia
    Alan Bensoussan · 2013
  29. Alpha-synuclein spreading pathology in Parkinson's disease: the influence of iron and the Rho-kinase inhibitor fasudil
    Karina Joppe · 2020
  30. What have we learnt from eDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?
    M. B. H. Y oudim · 2003
  31. Mitochondria: Bioenergetics and Predictive Therapeutics Using Vibrational Spectroscopy
    Jason Solocinski · 2021 · Deep Blue (University of Michigan)
  32. Parkinson’s Disease
    Barbara Stauch Slusher, Paul Jackson, Lisa A. Arvanitis · 1996 · Humana Press eBooks
  33. Etiological Considerations
    David M. A. Mann · 1997 · Springer eBooks
  34. Multi-omic analysis of the aging mouse brain
    Verena Kluever · 2021
  35. Multiscale X-Ray Analysis of Biological Cells and Tissues by Scanning Diffraction and Coherent Imaging
    Jan‐David Nicolas · 2018
  36. Morphochemical study of alpha-synuclein, iron and iron-containing proteins in the substantia nigra of the brain in Parkinson’s disease
    Сальков Владимир Николаевич, Р. М. Худоерков, Д. Н. Воронков, V. B. Sobolev · 2022 · Russian Journal of Archive of Pathology
  37. Parkinson’s Disease
    M. T. Silva, Anthony H.V. Schapira · 2001 · Humana Press eBooks
  38. Perturbations in levels of essential metals less severe in Parkinson’s disease without dementia than in Parkinson’s disease dementia
    Melissa Scholefield, Stephanie J. Church, Garth J. S. Cooper · 2025 · Metallomics
  39. Additional file 1 of Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis
    Molly E. V. Swanson, Emma L. Scotter, Leon C. D. Smyth, Helen C. Murray, Brigid Ryan, Turner, Clinton, Richard L. M. Faull, Dragunow, Mike, Maurice A. Curtis · 2020 · Figshare
  40. Additional file 1 of Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients
    Boyd Kenkhuis, Antonios Somarakis, de Haan, Lorraine, Oleh Dzyubachyk, Marieke E. Ijsselsteijn, de Miranda, Noel F. C. C., Boudewijn P. F. Lelieveldt, Dijkstra, Jouke, van Roon-Mom, Willeke M. C., Thomas Höllt et al. · 2021 · Figshare
  41. Efficacy and safety of deferiprone for Parkinson’s disease: a systematic review and meta-analysis of motor function and overall disease severity
    Ismail A Ibrahim, Mandy Elewa, Israa A. Solah, Moaz Ezz-Alarab, Rawan Gameel Hekal, Menna Ehab, A K Aref Alqurm, Rahma M. Almetwaly, Ayham R. A. Zidat · 2026 · Neurological Sciences
  42. Développement et validation d'une méthode de relaxométrie T2* bi-exponentielle en IRM cérébrale
    Maxime Michaud · 2020
  43. Towards the identification of targets and markers of Parkinson’s disease-associated neuroinflammation
    Cansu Yildirim-Balatan · 2021 · theses.fr (ABES)
  44. Metal Ions and Protein Aggregation: Unraveling Molecular Interactions and Theranostic Prospects in Proteinopathies
    Danilo Milardi, Jiyeon Han, Hyuck Jin Lee, Feng Ding, Yifat Miller, Peter Faller, Ashley Ian Bush, Peter John Crouch, David Isaac Finkelstein, Kay L. Double et al. · 2026 · Chemical Reviews
  45. A unifying hypothesis of alzheimer’s disease: III—Risk factors
    Heininger, Kurt · 2000 · Human Psychopharmacology: Clinical and Experimental